Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/18/2025

Treatment of Vitiligo in Teenagers

First-Line Topical Treatment Approach

  • The British Journal of Dermatology recommends topical calcineurin inhibitors (tacrolimus 0.1% or pimecrolimus 1%) as first-line therapy for teenagers with vitiligo, due to their comparable efficacy to potent corticosteroids but superior safety profile in this age group 1, 2, 3
  • Topical calcineurin inhibitors should be strongly preferred over potent corticosteroids in children and teenagers due to their better short-term safety profile, avoiding the risk of skin atrophy that commonly occurs with steroids 1, 2, 3
  • If calcineurin inhibitors are unavailable or not tolerated, use potent or very potent topical corticosteroids for a maximum of 2 months only, as skin atrophy is a common side effect with longer use 1, 3

When to Escalate to Phototherapy

  • Narrowband UVB (NB-UVB) phototherapy should be considered only when topical treatments fail, when vitiligo is widespread, or when localized disease significantly impacts quality of life 1, 3
  • NB-UVB is preferred over PUVA in teenagers due to greater efficacy, superior safety profile, and lack of clinical trial data for PUVA in children 1, 3
  • Reserve NB-UVB for darker skin types where cosmetic impact is greatest, and monitor with serial photographs every 2-3 months 1, 3
  • Apply a safety limit of no more than 200 treatments for skin types I-III, with more stringent limits than used for psoriasis due to increased susceptibility to photodamage in depigmented skin 1, 3

Critical Management Steps

  • Check thyroid function at initial assessment due to high prevalence of autoimmune thyroid disease in vitiligo patients 4
  • Document disease extent with serial photographs every 2-3 months using standardized scoring to objectively monitor treatment response 4

What NOT to Do

  • Never use oral dexamethasone to arrest disease progression due to unacceptable risk of side effects 1, 3
  • Never perform surgical treatments in teenagers, as there are no safety studies in children and adolescents 1, 3
  • Never extend potent topical corticosteroid use beyond 2 months to prevent irreversible skin atrophy 1, 3

Essential Adjunctive Care

  • Provide psychological interventions and counseling to improve coping mechanisms, as vitiligo can be particularly distressing and stigmatizing in adolescence 1, 2, 3
  • Offer parents psychological counseling as well, since family support is crucial for treatment adherence and emotional well-being 1, 2, 3
  • Recommend sunscreens for all depigmented areas due to increased sensitivity to sunburn and photodamage 1, 4

REFERENCES

4

Vitiligo Management Guidelines [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025